Haverford Trust Company’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-344
| Closed | -$218K | – | 417 |
|
|
2025
Q1 | $218K | Buy |
344
+25
| +8% | +$15.9K | ﹤0.01% | 380 |
|
|
2024
Q4 | $227K | Buy |
319
+12
| +4% | +$8.55K | ﹤0.01% | 374 |
|
|
2024
Q3 | $323K | Buy |
307
+22
| +8% | +$23.1K | ﹤0.01% | 356 |
|
|
2024
Q2 | $300K | Buy |
285
+5
| +2% | +$5.26K | ﹤0.01% | 360 |
|
|
2024
Q1 | $269K | Sell |
280
-64
| -19% | -$61.6K | ﹤0.01% | 347 |
|
|
2023
Q4 | $302K | Buy |
344
+21
| +7% | +$18.4K | ﹤0.01% | 326 |
|
|
2023
Q3 | $266K | Hold |
323
| – | – | ﹤0.01% | 325 |
|
|
2023
Q2 | $232K | Buy |
323
+3
| +0.9% | +$2.16K | ﹤0.01% | 339 |
|
|
2023
Q1 | $263K | Buy |
320
+29
| +10% | +$23.8K | ﹤0.01% | 328 |
|
|
2022
Q4 | $210K | Buy |
+291
| New | +$210K | ﹤0.01% | 323 |
|
|
2022
Q1 | – | Sell |
-341
| Closed | -$215K | – | 368 |
|
|
2021
Q4 | $215K | Buy |
341
+1
| +0.3% | +$630 | ﹤0.01% | 343 |
|
|
2021
Q3 | $206K | Sell |
340
-60
| -15% | -$36.4K | ﹤0.01% | 348 |
|
|
2021
Q2 | $223K | Buy |
+400
| New | +$223K | ﹤0.01% | 335 |
|
|
2021
Q1 | – | Sell |
-422
| Closed | -$204K | – | 321 |
|
|
2020
Q4 | $204K | Buy |
422
+22
| +6% | +$10.6K | ﹤0.01% | 293 |
|
|
2020
Q3 | $224K | Hold |
400
| – | – | ﹤0.01% | 266 |
|
|
2020
Q2 | $249K | Buy |
+400
| New | +$249K | ﹤0.01% | 257 |
|